Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD AJMC Nawigacja wpisu Is there a better to develop new drugs? – cosmosmagazine.com QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) – Business Wire
